In vivo adenovirus-mediated gene transfer for Parkinson's disease

Neurobiology of Disease

Volumn 4, Issue 3-4, 1997, Pages 280-287

  Horellou, Philippe ^a   Bilang Bleuel, Alicia ^a   Mallet, Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TYROSINE 3 MONOOXYGENASE; VIRUS VECTOR;

ADENOVIRUS; DOPAMINERGIC NERVE CELL; GENE TARGETING; MOLECULAR CLONING; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TRANSGENE; VIRUS GENE;

EID: 0030723933     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0162     Document Type: Article

References (47)

1. Akli S., Caillaud C., Vigne E., Stratford-Perricaudet L. D., Poenaru L., Perricaudet M., Kahn A., Peschanski M. Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3:1993;224-228.
2. Bajocchi G., Feldman S. H., Crystal R. G., Mastrangeli A. Directin vivo. Nature Genet. 3:1993;229-234.
3. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
4. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J. J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing GDNF prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. 94:1997;8818-8823.
5. Björklund A., Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:1979;555-560.
6. Brundin P., Strecker R. E., Lindvall O., Isacson O., Nilsson O. G., Barbin G., Prochiantz A., Forni C., Nieoullon A., Widner H., Gage F. H., Björklund A. Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann. NY Acad. Sci. 495:1987;473-496.
7. Choi-Lundberg D. L., Lin Q., Mohajeri H., Chang Y. N., Chiang Y. L., Hay C. M., Davidson B. L., Bohn M. C. GDNF delivered via an adenoviral vector protects rat dopaminergic neurons from degeneration. Science. 275:1997;838-841.
8. Davidson B. L., Allen E. D., Kozarsky K. F., Wilson J. M., Roessler B. J. A model system forin vivo. Nature Genet. 3:1993;219-223.
9. During M. J., Naegele J. R., O'Malley K. L., Geller A. I. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
10. Fisher L. J., Jinnah H. A., Kale L. C., Higgins G. A., Gage F. H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-Dopa. Neuron. 6:1991;371-380.
11. Friedmann T., Roblin R. Gene therapy for human genetic disease? Science. 175:1972;949-955.
12. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., Gerhardt G. A. Functional recovery in GDNF-treated parkinsonian monkeys. Nature. 380:1996;252-255.
13. Goldman M. J., Wilson J. M. Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69:1995;5951-5958.
14. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36:1977;59-72.
15. Horellou P., Guibert B., Leviel V., Mallet J. Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: Regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc. Natl. Acad. Sci. USA. 86:1989;7233-7237.
16. Horellou P., Brundin P., Kalén P., Mallet J., Björklund A. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron. 5:1990a;393-402.
17. Horellou P., Marlier L., Privat A., Mallet J. Behavioral effect of engineered cells that synthesize L-DOPA or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2:1990b;116-119.
18. Horellou P., Vigne E., Castel M. N., Barnéoud P., Colin P., Perricaudet M., Delaère P., Mallet J. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport. 6:1994;49-53.
19. Hou J. G., Lin L. F., Mytilineou C. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neuronsin vitro. J. Neurochem. 66:1996;74-82.
20. Huang S., Endo R. I., Nemerow G. R. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69:1995;2257-2263.
21. Kaplitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., O'Malley K. L., During M. J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8:1994;148-154.
22. Kuehn M. R., Bradley A., Robertson E. J., Evans M. J. A potential animal model for the human Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature. 326:1987;295-298.
23. Le Gal La Salle G., Robert J. J., Berrard S., Ridoux V., Stratford-Perricaudet L. D., Perricaudet M., Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
24. Lin L. F., Zhang T. J., Collins F., Armes L. G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
25. Lin L. F., Doherty D. H., Lile J. D., Bektesh S., Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
26. Lindvall O., Sawle G., Widner H., Rothwell J. C., Bjorklund A., Brooks D., Brundin P., Frackowiak R., Marsden C. D., Odin P. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:1994;172-180.
27. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K. L., Sawle G., Rothwell J. C., Marsden C. D., Björklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 247:1990;574-577.
28. Lundberg C., Horellou P., Mallet J., Bjorklund A. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene:in vitroin vivo. Exp. Neurol. 139:1996;39-53.
29. Mallet J., Blanot F., Boni C., Dumas S., Faucon-Biguet N., Grima B., Horellou P., Julien J. F., Kahn P., Lamouroux A. A molecular genetic approach to the study of catecholamines. Biochem. Soc. Trans. 15:1987;126-128.
30. Marsden C. D., Parkes J. D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1:1976;292-296.
31. Matsuse T., Namba Y., Ikeda K., Inoue S., Hosoi T., Ouchi Y., Fukuchi Y., Orimo H. Immunohistochemical and in situ hybridisation detection of adenovirus early region 1A (E1A) gene in the microglia of human brain tissue. J. Clin. Pathol. 47:1994;275-277.
32. Nandi A. K., Roginski R. S., Greeg R. G., Smithies O., Skoultchi A. I. Regulated expression of genes inserted at the human chromosomal β-globin locus by homologus recombination. Proc. Natl. Acad. Sci. USA. 85:1988;3845-3849.
33. Perlow M. J., Freed W. J., Hoffer B. J., Seiger Å., Olson L., Wyatt R. J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 204:1979;643-646.
34. Revah F., Horellou P., Vigne E., Le Gal la Salle G., Robert J.-J., Perricaudet M., Mallet J. Gene therapy of degenerative and genetic disorders of the central and peripheral nervous system using adenoviral vectors. Gene Transfer into Neurones - Towards Gene Therapy of Neurological Disorders. 1996;Wiley, Chichester. p. 81-92.
35. Ridoux V., Robert J. J., Zhang X., Perricaudet M., Mallet J., Le Gal La Salle G. Adenoviral vectors as functional retrograde neuronal tracers. Brain Res. 648:1994;171-175.
36. Rubin B. A., Rorke L. B. Adenovirus vaccines. Plotkin, Mortimer. Vaccines. 1988;492-512 Saunders, Philadelphia.
37. Sauer H., Oertel W. H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience. 59:1994;401-415.
38. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
39. Shults C. W., Kimber T., Martin D. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. NeuroReport. 7:1996;627-631.
40. Smithies O., Gregg R. G., Boggs S. S., Koralewski M. A., Kucherlapati R. S. Insertion of DNA sequences into the human chromosomal β-globin locus by homologus recombination. Nature. 317:1985;230-234.
41. Thomas K. R., Folger K. R., Capecchi M. R. High frequency targeting of genes to specific sites in the mammalian genome. Cell. 44:1986;419-428.
42. Tomac A., Widenfalk J., Lin L.-F., Kohno T., Ebendal T., Hoffer B. J., Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA. 92:1995;8274-8278.
43. Ungerstedt U., Arbuthnott G. W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
44. Wickham T. J., Filardo E. J., Cheresh D. A., Nemerow G. R. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:1994;257-264.
45. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
46. Winkler C., Sauer H., Lee C. S., Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's Disease. J. Neurosci. 16:1996;7206-7215.
47. Wolfe J. D., Deshmane S. L., Fraser N. W. Herpes virus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nature Genet. 1:1992;379-384.